These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Dong J; Cross RW; Doyle MP; Kose N; Mousa JJ; Annand EJ; Borisevich V; Agans KN; Sutton R; Nargi R; Majedi M; Fenton KA; Reichard W; Bombardi RG; Geisbert TW; Crowe JE Cell; 2020 Dec; 183(6):1536-1550.e17. PubMed ID: 33306954 [TBL] [Abstract][Full Text] [Related]
4. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay. Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399 [TBL] [Abstract][Full Text] [Related]
6. Characterization of germline antibody libraries from human umbilical cord blood and selection of monoclonal antibodies to viral envelope glycoproteins: Implications for mechanisms of immune evasion and design of vaccine immunogens. Chen W; Streaker ED; Russ DE; Feng Y; Prabakaran P; Dimitrov DS Biochem Biophys Res Commun; 2012 Jan; 417(4):1164-9. PubMed ID: 22226962 [TBL] [Abstract][Full Text] [Related]
7. Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses. Zhu Z; Dimitrov AS; Chakraborti S; Dimitrova D; Xiao X; Broder CC; Dimitrov DS Expert Rev Anti Infect Ther; 2006 Feb; 4(1):57-66. PubMed ID: 16441209 [TBL] [Abstract][Full Text] [Related]
8. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model. Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514 [TBL] [Abstract][Full Text] [Related]
9. Vaccines to Emerging Viruses: Nipah and Hendra. Amaya M; Broder CC Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Hendra and Nipah virus infection in humans. Escaffre O; Borisevich V; Rockx B J Infect Dev Ctries; 2013 Apr; 7(4):308-11. PubMed ID: 23592639 [TBL] [Abstract][Full Text] [Related]
11. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody. Zhu Z; Bossart KN; Bishop KA; Crameri G; Dimitrov AS; McEachern JA; Feng Y; Middleton D; Wang LF; Broder CC; Dimitrov DS J Infect Dis; 2008 Mar; 197(6):846-53. PubMed ID: 18271743 [TBL] [Abstract][Full Text] [Related]
12. Construction of the safe neutralizing assay system using pseudotyped Nipah virus and G protein-specific monoclonal antibody. Bae SE; Kim SS; Moon ST; Cho YD; Lee H; Lee JY; Shin HY; Lee HJ; Kim YB Biochem Biophys Res Commun; 2019 Jun; 513(4):781-786. PubMed ID: 30995971 [TBL] [Abstract][Full Text] [Related]
13. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. Bossart KN; Crameri G; Dimitrov AS; Mungall BA; Feng YR; Patch JR; Choudhary A; Wang LF; Eaton BT; Broder CC J Virol; 2005 Jun; 79(11):6690-702. PubMed ID: 15890907 [TBL] [Abstract][Full Text] [Related]
15. [Emerging respiratory infections caused by pneumotropic viruses]. Lange C; Schütt M; Brodt HR Dtsch Med Wochenschr; 2005 Jun; 130(22):1385-91. PubMed ID: 15915382 [No Abstract] [Full Text] [Related]
16. Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA. Chiang CF; Lo MK; Rota PA; Spiropoulou CF; Rollin PE Virol J; 2010 Jun; 7():115. PubMed ID: 20525276 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies against the nucleocapsid proteins of henipaviruses: production, epitope mapping and application in immunohistochemistry. Xiao C; Liu Y; Jiang Y; Magoffin DE; Guo H; Xuan H; Wang G; Wang LF; Tu C Arch Virol; 2008; 153(2):273-81. PubMed ID: 17978885 [TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibodies as candidate therapeutics against emerging viruses. Jin Y; Lei C; Hu D; Dimitrov DS; Ying T Front Med; 2017 Dec; 11(4):462-470. PubMed ID: 29159596 [TBL] [Abstract][Full Text] [Related]
19. A treatment for and vaccine against the deadly Hendra and Nipah viruses. Broder CC; Xu K; Nikolov DB; Zhu Z; Dimitrov DS; Middleton D; Pallister J; Geisbert TW; Bossart KN; Wang LF Antiviral Res; 2013 Oct; 100(1):8-13. PubMed ID: 23838047 [TBL] [Abstract][Full Text] [Related]
20. Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus. Berhane Y; Berry JD; Ranadheera C; Marszal P; Nicolas B; Yuan X; Czub M; Weingartl H J Virol Methods; 2006 Mar; 132(1-2):59-68. PubMed ID: 16226320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]